The Innovation Co-development Unit (ICU) is responsible for working closely with research teams as well as for bringing together the expertise needed to co-develop each R&D project.
Typically, this expertise includes project management, legal support, regulatory strategy development, networking with industrial partners and patient associations.
What we offer
Dynamic Living lab
TransMedTech adopts a Living Lab approach in all its activities, which mobilizes and brings together researchers, engineers, students, physicians, caregivers, industry partners, government policy makers and patients. We promote transdisciplinary and cross-sectoral collaborative research, open innovation and creativity.
Industry standard processes
The TransMedTech Institute has achieved international ISO 13485: 2016 certification for its quality management system. This certification facilitates the transfer of innovations from academia to industry, accelerating the deployment of medical technologies in the healthcare system.
A personalized and collaborative coaching is offered to research teams in order to support them in their medical technology projects by providing expertise in project management, legal support, development of regulatory strategies, networking with industrial partners, etc.
Innovative and collaborative ecosystem
The TransMedTech ecosystem offers access to interdisciplinary teams, proximity to three hospitals and two universities, the services and expertise of several technology platforms, students working on large-scale R&D projects, international partners, not to mention to the users of the technologies.
Our project support process
Our process begins with a comprehensive analysis of needs, technical and economic prospects, and expertise, which, after a number of iterative stages (which may include stakeholders from outside the project), results in the definition of an R&D project.
With the project conceptualized as a co-development plan, the scope of the project is refined, the necessary expertise and infrastructure are identified and assembled, and the technological development, regulatory and intellectual property management strategy, along with the industry partnership, financial structure and timetable are fine-tuned.
The project’s technical and economic feasibility are evaluated by an outside committee of experts.
After the co-development plan is finalized, the project is conducted by the research teams and supported by iTMT in living-lab co-development mode.
Steps 5 and 6
The medical technology developed is then validated. The transfer process, and potentially the implementation, are then carried out with the support of iTMT, in interaction with the various stakeholders.
To submit a project application
To tell us about your needs or to submit a project application, you must first contact the TransMedTech team to establish your eligibility. We may also discuss the support needed to achieve your goals.
Applications may be submitted at any time by researchers, clinicians, health care facility managers or industry partners. The TransMedTech team will assist you in completing the research team to meet the eligibility criteria below, if applicable.
- The project must fall within one of TransMedTech’s medical axes and sectors.
- The principal investigator of the project must hold a regular position at one of the TransMedTech founding institutions, i.e., Polytechnique Montréal, Université de Montréal, CHU Sainte-Justine, CHUM or Jewish General Hospital.
- The team should be composed of at least two researchers from different disciplines (clinician, engineer, biologist, etc.) and involve the relevant stakeholders (patient-partners, users, clinicians, administrators, etc.) for the development and the subsequent steps leading to implantation.